These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 594750)

  • 21. Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial.
    Shenoy PD; Kumar S; Jha LK; Choudhary SK; Singh U; Misra R; Agarwal V
    Rheumatology (Oxford); 2010 Dec; 49(12):2420-8. PubMed ID: 20837499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Raynaud's disease and phenomenon].
    Vilardell Tarrés M
    Med Clin (Barc); 1983 Dec; 81(18):808-10. PubMed ID: 6656450
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis.
    Kamata Y; Kamimura T; Iwamoto M; Minota S
    Clin Exp Dermatol; 2005 Jul; 30(4):451. PubMed ID: 15953103
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thermography in evaluating therapy in Raynaud's disease].
    Litmanovitch J; Shilo R; Chayen M
    Harefuah; 1972 Jun; 82(11):503-6. PubMed ID: 5068900
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methods for studying vasodilator agents in Raynaud's phenomenon].
    Planchon B; de Faucal P
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():75-7. PubMed ID: 2111690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of Raynaud's phenomenon].
    Boccalon H; Monin A; Reggy M
    Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023
    [No Abstract]   [Full Text] [Related]  

  • 27. Hexopal in Raynaud's disease.
    Aylward M
    J Int Med Res; 1979; 7(6):484-91. PubMed ID: 520652
    [No Abstract]   [Full Text] [Related]  

  • 28. Syncope and Raynaud's disease.
    Guiloff RJ; Rajakulendran S; Angus-Leppan H
    Arch Neurol; 2012 May; 69(5):608-13. PubMed ID: 22248476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome.
    Levy Y; Sherer Y; Shoenfeld Y
    Isr Med Assoc J; 2000 Dec; 2(12):960-1. PubMed ID: 11344792
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raynaud's phenomenon of the nipple: a preventable cause of breastfeeding failure?
    Lawlor-Smith LS; Lawlor-Smith CL
    Med J Aust; 1997 Apr; 166(8):448. PubMed ID: 9140358
    [No Abstract]   [Full Text] [Related]  

  • 32. [Raynaud's phenomenon: diagnostic and therapeutic aspects].
    Soro P; Occhioni G; Spissu M; Trignano M; Dettori G; Bacciu PP; Biglioli P
    Chir Ital; 1981 Jun; 33(3):647-60. PubMed ID: 7307205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of patients with secondary Raynaud's syndrome.
    Ehrly AM
    Acta Chir Scand Suppl; 1976; 465():92-5. PubMed ID: 1069443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of pinacidil in patients with primary Raynaud's phenomenon.
    Dompeling EC; Smit AJ
    Vasa Suppl; 1992; 34():34-7. PubMed ID: 1529416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
    Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
    J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic image. A breastfeeding woman with a painful, blue nipple].
    Velstra B; Bijlsma TS
    Ned Tijdschr Geneeskd; 2009; 153():B343. PubMed ID: 19785781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 39. Prazosin relieves Raynaud's vasospasm.
    Waldo R
    JAMA; 1979 Mar; 241(10):1037. PubMed ID: 762741
    [No Abstract]   [Full Text] [Related]  

  • 40. [Raynaud's syndrome].
    Mishima Y
    Ryumachi; 1983 Oct; 23(5):370-5. PubMed ID: 6369565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.